<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Drug Policy</journal-id><journal-id journal-id-type="iso-abbrev">Int J Drug Policy</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The International journal on drug policy</journal-title></journal-title-group><issn pub-type="ppub">0955-3959</issn><issn pub-type="epub">1873-4758</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10117037</article-id><article-id pub-id-type="pmcid-ver">PMC10117037.1</article-id><article-id pub-id-type="pmcaid">10117037</article-id><article-id pub-id-type="pmcaiid">10117037</article-id><article-id pub-id-type="manuscript-id">NIHMS1879022</article-id><article-id pub-id-type="pmid">35965159</article-id><article-id pub-id-type="doi">10.1016/j.drugpo.2022.103803</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1879022</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1879022</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2314-8924</contrib-id><name name-style="western"><surname>Stopka</surname><given-names initials="TJ">Thomas J.</given-names></name><degrees>PhD, MHS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rottapel</surname><given-names initials="R">Rebecca</given-names></name><degrees>MPH, MS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ferguson</surname><given-names initials="WJ">Warren J.</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pivovarova</surname><given-names initials="E">Ekaterina</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Del Toro-Mejias</surname><given-names initials="L">Lizbeth</given-names></name><degrees>MS</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Friedmann</surname><given-names initials="PD">Peter D.</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3478-9957</contrib-id><name name-style="western"><surname>Evans</surname><given-names initials="EA">Elizabeth A.</given-names></name><degrees>PhD, MA</degrees><xref rid="A4" ref-type="aff">d</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Public Health and Community Medicine, Tufts University School of Medicine, 200 Harrison Avenue, Boston, MA, United States, 02111.</aff><aff id="A2"><label>b</label>Department of Family Medicine and Community Health, University of Massachusetts Chan Medical School, 55 Lake Avenue North, Worcester, MA, United States, 01655.</aff><aff id="A3"><label>c</label>University of Massachusetts Chan Medical School&#8211;Baystate, 55 N Lake Ave, Worcester, MA 01655, United States, and Baystate Health, 759 Chestnut St, Springfield, MA, United States, 01199.</aff><aff id="A4"><label>d</label>Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, 312 Arnold House, 715 North Pleasant Street, Amherst, MA, United States, 01003</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Thomas J. Stopka, PhD, MHS, Associate Professor, Department of Public Health and Community Medicine, Clinical and Translational Science Institute, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, <email>Thomas.Stopka@tufts.edu</email>, Phone: (617) 636-2110, Fax: (617) 636-3810</corresp><fn fn-type="COI-statement" id="FN1"><p id="P74"><bold>CONFLICT OF INTEREST DECLARATION:</bold> The authors report no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>12</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>11</day><month>8</month><year>2022</year></pub-date><volume>110</volume><issue-id pub-id-type="pmc-issue-id">433865</issue-id><fpage>103803</fpage><lpage>103803</lpage><pub-history><event event-type="nihms-submitted"><date><day>18</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>01</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-16 09:25:39.563"><day>16</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1879022.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">People released from jail are at elevated opioid overdose risk. Medications for opioid use disorder (MOUD) are effective in reducing overdoses. MOUD treatment was recently mandated in seven Massachusetts jails, but little is known about barriers and facilitators to treatment continuity post-release. We aimed to assess MOUD provider perspectives on treatment continuity among people released from jail.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We conducted qualitative interviews with 36 medical, supervisory, and administrative staff at MOUD programs that serve jail-referred patients. We used the Exploration, Preparation, Implementation, and Sustainment (EPIS) implementation science framework to guide development of instruments, codes, and analyses. We employed deductive and inductive coding, and a grounded theory analytical approach to identify salient themes.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Inner context findings highlighted necessary adjustments among jail staff to approve MOUD treatment, especially with agonist medications that were previously considered contraband. Participants perceived that some staff within jails favored abstinence-based recovery, viewing agonists as a crutch. Bridging results highlighted the importance of interagency communication and coordination to ensure information transfer for seamless treatment continuity in the community post-release. Pre-release planning, release on pre-scheduled dates, medication provision to cover gaps between jail release and intake at community MOUD sites, and exchange of treatment information across agencies were viewed as paramount to success. Unexpected early releases and releases from court were viewed as barriers to treatment coordination. Outer context domains were largely tied to social determinants of health. Substantial barriers to treatment continuity included shelter, food security, employment, transportation, and insurance reactivation.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Through qualitative interviews with community-based MOUD staff, we identified salient barriers and facilitators to treatment continuity post-release from jails. Findings point to needed investments in care coordination, staffing, and funding to strengthen jail-to-community-based MOUD treatment, removing barriers to continuity, and decreasing opioid overdose deaths during this high-risk transition.</p></sec></abstract><kwd-group><kwd>Medication for opioid use disorder</kwd><kwd>treatment continuity</kwd><kwd>jails</kwd><kwd>Massachusetts</kwd><kwd>qualitative</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>